With reference to Pharmexa's stock exchange release no. 21 published May 13, 2009, it can now be confirmed that the Danish Commerce and Companies Agency have registered the resolutions adopted at the Ordinary General Meeting on April 28, 2009 and the Extraordinary General Meeting on May 5, 2009. Pharmexa changes the company's name to Affitech A/S and the board of directors in the company consists of Dr. Keith McCullagh (Chairman), Mr. Ole Steen Andersen (Vice-Chairman), Mr. Steinar Engelsen, Mr. Arne Handeland, Mr. Påll Rødseth and Mr. Michel Pettigrew. The registration of the capital increase in connection to the combination of Affitech AS and Pharmexa A/S is expected to be registered within the next few days when the transfer of the shares between Affitech AS and Pharmexa A/S has been completed. Hørsholm, June 2, 2009 Achim Kaufhold Chief Executive Officer Additional information: Claude Mikkelsen, Senior Vice President, Finance & Investor Relations, tel +45 4516 2525 or +45 4060 2558
Registration of resolutions adopted at Pharmexa's Ordinary General Meeting and Extraordinary General Meeting
| Source: Affitech A/S